Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 10, 2026
Why Is USA Rare Earth (USAR) Stock Up +0.52% Today?

Why Is USA Rare Earth (USAR) Stock Up +0.52% Today?

Key Takeaways

  • USA Rare Earth (USAR) shares rose 0.52% in Monday morning trading, adding $0.10 to reach $19.43, building on Friday's powerful 11.03% rally.
  • Q2 2026 earnings are due after today's closing bell, the primary catalyst keeping traders engaged and positioning for potential upside.
  • The merger with Texas Mineral Resources Corp. (TMRC) closed on Friday, securing full ownership of the Round Top heavy rare earth deposit in West Texas and fueling last week's 29.3% surge.
  • Pre-market activity pushed shares as high as $19.64 before early-session profit-taking trimmed gains, a pattern consistent with traders locking in profits ahead of an uncertain earnings print.
  • Broader rare earth sector sentiment remains supportive, driven by U.S. government reshoring initiatives and continued efforts to reduce dependence on Chinese supply chains.
  • Traders are watching the after-hours earnings release and conference call for updates on the Stillwater magnet facility ramp, the Pela Ema mine acquisition in Brazil, and cash burn rates.

Opening Summary

Shares of USAR, representing USA Rare Earth, Inc. — a domestic builder of rare earth magnet and critical mineral supply chains serving defense, automotive, semiconductor, and energy sectors — edged higher by 0.52% in Monday's trading session. The stock traded at $19.43, up from Friday's closing price of $19.33, as investors positioned ahead of the company's second-quarter 2026 earnings report scheduled for release after the market close. The modest intraday gain follows a blockbuster 11.03% surge on Friday, when the company confirmed the completion of its merger with Texas Mineral Resources Corp.

Earnings Anticipation Drives Cautious Positioning

The dominant event governing Monday's trading is the imminent release of USA Rare Earth's Q2 2026 financial results. The company is expected to report revenue of approximately $6.45 million, with analysts forecasting a loss of $0.19 per share. While these numbers are modest for a company carrying a $4.73 billion market capitalization, the market's attention is squarely on operational milestones rather than near-term profitability. Investors are seeking clarity on the commercial ramp of Phase 1a magnet production at the Stillwater, Oklahoma facility, which began commissioning in March 2026 and targets 600 metric tons per year by year-end. Any commentary on customer offtake agreements, production yields, or supply-chain integration following the TMRC deal could materially move the stock in after-hours trading. The pre-market bid that lifted shares to $19.64 — a 1.60% premium to Friday's close — suggests some traders were building positions ahead of the release, though early regular-session activity saw those gains partially fade.

TMRC Merger Completion Anchors the Strategic Narrative

Friday's formal closing of the Texas Mineral Resources Corp. acquisition represents a transformative milestone for USA Rare Earth. The all-stock transaction, valued at approximately $73 million and executed through a two-step subsidiary merger, grants USAR full ownership of the Round Top heavy rare earth and critical minerals deposit in West Texas. The deal strengthens the company's mine-to-magnet vertical integration thesis at a time when Washington is actively funding domestic rare earth independence. Notably, USAR signed a letter of intent with the U.S. Government in January 2026 for up to $1.6 billion in funding to construct a domestic supply chain. The TMRC merger not only de-risks the company's raw material access but also consolidates its position as one of only a handful of Western-aligned rare earth processors capable of competing with China's dominant market position. The 29.3% rally over the past five trading sessions — from $14.95 on July 31 to $19.33 at Friday's close — reflects the market's reassessment of USAR's strategic value following the deal's completion.

Sector Tailwinds and Reshoring Momentum

USA Rare Earth's move also benefits from sustained macro-level support for the rare earth mining and processing sector. The U.S. government's determination to decouple critical mineral supply chains from China has created a favorable policy environment for domestic producers. China currently controls well in excess of 90% of the rare earth market, including up to 99% of certain elements, a concentration that policymakers in Washington view as a national security vulnerability. USAR, alongside peers such as MP Materials, is a direct beneficiary of reshoring incentives and defense-linked demand for neodymium-iron-boron (NdFeB) magnets used in precision-guided weapons, satellite systems, and electric vehicle traction motors. This structural backdrop provides a valuation floor that supports risk-taking into catalysts like earnings and merger completions, even as the company remains deeply unprofitable on a GAAP basis.

Market Context and Trading Activity

Trading volume on Monday was consistent with the elevated pattern observed over the prior week, when average daily volume exceeded 14 million shares compared to a three-month average of roughly 10 million. The stock opened near $19.46, briefly touched $19.61, and settled into a narrow range around $19.40 in the first hour of trading — behavior consistent with a market waiting for a binary catalyst. From a technical perspective, USAR has recovered sharply from its July 29 low of $12.93 and is now challenging its 50-day moving average near $19.96, a level that acted as resistance during the late-June selloff. A convincing break above that threshold, possibly catalyzed by a strong earnings report, could invite momentum-driven buying. Broader equity indices were mixed, with the S&P 500 and Nasdaq Composite trading near flat, indicating that USAR's move was driven by company-specific rather than macro factors.

What Comes Next for USAR

The immediate focus is squarely on this afternoon's Q2 earnings release and the 5 p.m. ET conference call. Beyond the headline numbers, investors will scrutinize forward guidance, updates on the Stillwater magnet production ramp, progress on the Pela Ema mine acquisition in Brazil (via the pending Serra Verde transaction), and the integration roadmap for the newly acquired Round Top deposit. The appointment of Thras Moraitis as incoming CEO, effective October 1, 2026, adds a leadership transition narrative that may also feature in management's prepared remarks. Risks include continued cash burn — operating cash flow was negative $57.1 million over the trailing twelve months — and the inherent execution challenges of scaling multiple capital-intensive projects simultaneously. However, with $1.75 billion in cash and equivalents on the balance sheet as of the most recent quarter, the company has ample runway to fund its ambitious buildout. Any surprises in the earnings release, positive or negative, will likely generate significant after-hours volatility.

Trending AI Robots

For traders seeking to navigate volatile stocks like USAR with a systematic, data-driven approach, Tickeron offers a curated Trending AI Robots page featuring hundreds of AI-powered trading bots. These bots cover thousands of tickers across diverse strategies, timeframes, and performance profiles, but only the strongest performers under current market conditions are highlighted in the Trending AI Robots section. Whether you are focused on momentum, swing trading, or sector rotation, exploring AI-driven signals can provide an additional layer of decision-making support in fast-moving markets like rare earth equities.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: USAR

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


USAR's RSI Indicator ascending out of oversold territory

The RSI Oscillator for USAR moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 8 similar instances when the indicator left oversold territory. In of the 8 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on USAR as a result. In of 41 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for USAR just turned positive on July 31, 2026. Looking at past instances where USAR's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where USAR advanced for three days, in of 127 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USAR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

USAR broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for USAR entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. USAR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.518) is normal, around the industry mean (11.557). P/E Ratio (20.267) is within average values for comparable stocks, (130.643). USAR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.295). USAR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (344.828) is also within normal values, averaging (294.079).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USAR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Vale SA (NYSE:VALE).

Industry description

The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.

Market Cap

The average market capitalization across the Other Metals/Minerals Industry is 9.45B. The market cap for tickers in the group ranges from 230 to 225B. BHP holds the highest valuation in this group at 225B. The lowest valued company is BAJFF at 230.

High and low price notable news

The average weekly price growth across all stocks in the Other Metals/Minerals Industry was 16%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -17%. WWR experienced the highest price growth at 86%, while EMAT experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Other Metals/Minerals Industry was 176%. For the same stocks of the Industry, the average monthly volume growth was 102% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 78
Price Growth Rating: 56
SMR Rating: 92
Profit Risk Rating: 87
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
USAR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry OtherMetalsMinerals

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.